Leukemia Clinical Trials

Showing 3521-3540 of 10,987 trials

A Prospective, Single-center, Single-arm, Pivotal Trial of the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System

NCT05715827

The goal of this clinical trial is to test the safety and effectiveness of the Medtronic Hugo™ RAS System in patients undergoing a prostatectomy or a cholecystectomy. A minimum of 40 subjects will be enrolled at single site in Republic of Korea: 20 for prostatectomy and 20 for cholecystectomy. All participants will be followed for 30 days (±7 days) post-procedure.

Prostate CancerCholelithiasesCholecystitis+1 more

Medtronic - MITG42 participantsStarted Feb 2023

Seoul, Jongno-gu, South Korea

COMPLETED

Functional Lung Imaging With DECT and 4DCT

NCT04702607

The basic premise of this pilot study is to enroll 40 patients over 3 years who have Stage II, III, or IV non-small cell lung cancer and are planned for definitive treatment with concurrent chemoradiation where a contrast enhanced 4DCT is planned.

Non Small Cell Lung Cancer

Abramson Cancer Center at Penn Medicine40 participantsStarted Jan 2021

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 1

A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02236013

The purpose of this study is to describe the dose limiting toxicities (DLT) and define the maximum tolerated dose (MTD) of ASP2215 when combined with cytarabine/idarubicin or daunorubicin remission induction in a 7+3 schedule. Safety and tolerability of ASP2215 will also be evaluated. This study will also characterize the pharmacokinetics (PK) of ASP2215 when given in combination with cytarabine/idarubicin or cytarabine/daunorubicin remission induction and high-dose cytarabine (HiDAC) consolidation therapy in newly diagnosed acute myeloid leukemia as well as evaluate the effect of ASP2215 on the PK of cytarabine.

Acute Myeloid Leukemia

Astellas Pharma Global Development, Inc.80 participantsStarted Jan 2015

Los Angeles, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +7 more locations

A Prospective, Single-center, Single-arm, Pivotal Trial of the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System

Functional Lung Imaging With DECT and 4DCT

A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

Related Searches

Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic Leukemia

Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

End-of-life Communication From a Chinese Perspective

Comparison of the Effects of Different Exercise Protocols in Individuals with Hallux Valgus

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors

The Relationship Between Allergic Rhinitis, Forward Head Posture, and Anxiety Levels in Iranian Children

Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.

Quest to Analyze One Thousand Humans Meditating

The Prognostic Role of Fibrinogen to Albumin Ratio in Acute Leukemia Patients

Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer

GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.

Cemiplimab for Secondary Angiosarcomas

A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

Intelligent Analysis and Clinical Validation of Cerebral Small Vessel Disease on Magnetic Resonance Imaging：A Multi-center Study